Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pulmonary Protection Trial
NCT01614951Phase 4Completed
- Sponsor
- Rigshospitalet
- Start
- Jul 2012
- Primary completion
- Nov 2013
- Modality
- Device-based Delivery
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of HTK Custodiol in Abnormal lung function (3 arms), sponsored by Rigshospitalet. Primary endpoint: Oxygenation Index. Started Jul 2012; status: completed.
02
Drugs
HTK Custodiol
03
Conditions
Abnormal lung function
Beyond the preview
Go deeper on NCT01614951.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01614951.